Efficacy and Safety Study of the HS-25 Combination With Atorvastatin in Subjects With Hypercholesterolemia in Coronary Heart Diseases — HS-25-III-02  

Hypercholesterolemia in Coronaory Heart Disease Clinical Trial

Official title: Randomized,Double Blind,Double Dummy, Multi-center Study of Efficacy and Safety of HS-25 Combination With Atorvastatin in Subjects With Hypercholesterolemia in Coronary Heart Diseases

Status Completed

Clinical Trial Summary

To determine the efficacy of HS-25 (20mg) in reducing low density lipoprotein-cholesterol (LDL-C) levels after a 12-week period of treatment in combination with Atorvastatin in subjects with hypercholesterolemia and coronary heart diseases; To determine the safety of HS-25 (20mg) combination with Atorvastatin in subjects with hypercholesterolemia and coronary heart diseases

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Coronary Artery Disease
• Coronary Disease
• Heart Diseases
• Hypercholesterolemia
• Hypercholesterolemia in Coronaory Heart Disease
• Myocardial Ischemia

• NCT number: NCT03433196
• Study type: Interventional
• Source: Zhejiang Hisun Pharmaceutical Co. Ltd.
• Status: Completed
• Phase: Phase 3
• Start date: June 7, 2016
• Completion date: October 10, 2018